
Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf

Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf
Founded: 2020 (Paris)
Product: AI-enabled prenatal ultrasound workflow software (Sonio Detect)
Regulatory status: Sonio Detect: FDA 510(k) clearance and CE marked
Exit / M&A: Acquired by Samsung Medison in 2024
Recent funding: Series A $14M (2023)
Prenatal ultrasound quality, workflow automation, and reporting in OB-GYN practice.
2020
Software Development
€5,000,000
Announced June 2022
€10,000,000
Reported as €2.5M grant + €7.5M equity
$14,000,000
Participation from Elaia, Bpifrance, OneRagtime and angel investors
Company became a wholly-owned subsidiary of Samsung Medison
“Includes institutional backers (Cross Border Impact Ventures, Elaia, Bpifrance, OneRagtime) and EIC support”
| Company |
|---|